tezepelumab Archives -

The FDA has approved AstraZeneca and Amgen’s severe asthma hope tezepelumab, exonerating the drugmakers’ decision to press ahead

Relief for AZ, Amgen as FDA okays severe asthma hope tezepelumab

https://pharmaphorum.com/news/relief-for-az-amgen-as-fda-okays-severe-asthma-hope-tezepelumab/

Amgen and AstraZeneca haven’t won approval or announced a price for their severe asthma therapy tezepelumab should it

ICER says Amgen’s tezepelumab ‘likely to be too expensive’

https://pharmaphorum.com/news/icer-says-amgens-tezepelumab-likely-to-be-too-expensive/

Amgen and partner AstraZeneca have said their recently filed severe asthma drug tezepelumab has shown impressive results in

Amgen builds case for severe asthma drug tezepelumab

https://pharmaphorum.com/news/amgen-builds-case-for-severe-asthma-drug-tezepelumab/

The FDA has started a priority review of AstraZeneca and Amgen’s severe asthma antibody tezepelumab, setting a date

AZ, Amgen get speedy FDA review for asthma drug tezepelumab

https://pharmaphorum.com/news/az-amgen-get-speedy-fda-review-for-severe-asthma-drug-tezepelumab/

AstraZeneca says full data from the NAVIGATOR trial of tezepelumab in severe asthma keep it on course to

AZ trumpets tezepelumab data as filing for severe asthma looms

https://pharmaphorum.com/news/az-trumpets-tezepelumab-data-as-filing-for-severe-asthma-looms/

AstraZeneca and Amgen looked on course to cruise to approval of their severe asthma drug tezepelumab with a

AZ, Amgen’s asthma hope tezepelumab flunks phase 3 trial

https://pharmaphorum.com/news/az-amgens-asthma-hope-tezepelumab-flunks-phase-3-trial/

The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after

Breakthrough designation AstraZeneca’s severe asthma drug

https://pharmaphorum.com/news/astrazeneca-asthma-breakthrough/

tezepelumab